Synergistic effects of the sesquiterpene lactone, EPD, with cisplatin and paclitaxel in ovarian cancer cells

10.1186/s13046-015-0157-2

Saved in:

Bibliographic Details
Main Authors:	Van Haaften, C, Boot, A, Corver, W.E, Van Eendenburg, J.D, Trimbos, B.J, Van Wezel, T
Other Authors:	DUKE-NUS MEDICAL SCHOOL
Format:	Article
Published:	2020
Subjects:	caspase 3 cisplatin dye eremophila 1(10) 11(1230)dien 12,8beta olide paclitaxel presto blue sesquiterpene lactone derivative unclassified drug antineoplastic agent lactone sesquiterpene apoptosis Article cancer resistance cell specificity cell viability controlled study drug cytotoxicity drug efficacy drug potentiation drug selectivity female flow cytometry G2 phase cell cycle checkpoint human human cell in vitro study incubation time JC cell line JC pl cell line ovarian cancer cell line ovary cancer OVCAR 3 cell line priority journal SK OV 3 cell line skin fibroblast Ovarian Neoplasms pathology tumor cell line Antineoplastic Agents Antineoplastic Combined Chemotherapy Protocols Cell Line, Tumor Cisplatin Drug Synergism Female Humans Lactones Paclitaxel Sesquiterpenes
Online Access:	https://scholarbank.nus.edu.sg/handle/10635/174127
Tags:	Add Tag No Tags, Be the first to tag this record!
Institution:	National University of Singapore

id	sg-nus-scholar.10635-174127
record_format	dspace
spelling	sg-nus-scholar.10635-1741272023-09-20T08:54:09Z Synergistic effects of the sesquiterpene lactone, EPD, with cisplatin and paclitaxel in ovarian cancer cells Van Haaften, C Boot, A Corver, W.E Van Eendenburg, J.D Trimbos, B.J Van Wezel, T DUKE-NUS MEDICAL SCHOOL caspase 3 cisplatin dye eremophila 1(10) 11(1230)dien 12,8beta olide paclitaxel presto blue sesquiterpene lactone derivative unclassified drug antineoplastic agent cisplatin lactone paclitaxel sesquiterpene apoptosis Article cancer resistance cell specificity cell viability controlled study drug cytotoxicity drug efficacy drug potentiation drug selectivity female flow cytometry G2 phase cell cycle checkpoint human human cell in vitro study incubation time JC cell line JC pl cell line ovarian cancer cell line ovary cancer OVCAR 3 cell line priority journal SK OV 3 cell line skin fibroblast drug potentiation Ovarian Neoplasms pathology tumor cell line Antineoplastic Agents Antineoplastic Combined Chemotherapy Protocols Cell Line, Tumor Cisplatin Drug Synergism Female Humans Lactones Ovarian Neoplasms Paclitaxel Sesquiterpenes 10.1186/s13046-015-0157-2 Journal of Experimental and Clinical Cancer Research 34 1 38 2020-09-03T10:34:55Z 2020-09-03T10:34:55Z 2015 Article Van Haaften, C, Boot, A, Corver, W.E, Van Eendenburg, J.D, Trimbos, B.J, Van Wezel, T (2015). Synergistic effects of the sesquiterpene lactone, EPD, with cisplatin and paclitaxel in ovarian cancer cells. Journal of Experimental and Clinical Cancer Research 34 (1) : 38. ScholarBank@NUS Repository. https://doi.org/10.1186/s13046-015-0157-2 17569966 https://scholarbank.nus.edu.sg/handle/10635/174127 Unpaywall 20200831
institution	National University of Singapore
building	NUS Library
continent	Asia
country	Singapore Singapore
content_provider	NUS Library
collection	ScholarBank@NUS
topic	caspase 3 cisplatin dye eremophila 1(10) 11(1230)dien 12,8beta olide paclitaxel presto blue sesquiterpene lactone derivative unclassified drug antineoplastic agent cisplatin lactone paclitaxel sesquiterpene apoptosis Article cancer resistance cell specificity cell viability controlled study drug cytotoxicity drug efficacy drug potentiation drug selectivity female flow cytometry G2 phase cell cycle checkpoint human human cell in vitro study incubation time JC cell line JC pl cell line ovarian cancer cell line ovary cancer OVCAR 3 cell line priority journal SK OV 3 cell line skin fibroblast drug potentiation Ovarian Neoplasms pathology tumor cell line Antineoplastic Agents Antineoplastic Combined Chemotherapy Protocols Cell Line, Tumor Cisplatin Drug Synergism Female Humans Lactones Ovarian Neoplasms Paclitaxel Sesquiterpenes
spellingShingle	caspase 3 cisplatin dye eremophila 1(10) 11(1230)dien 12,8beta olide paclitaxel presto blue sesquiterpene lactone derivative unclassified drug antineoplastic agent cisplatin lactone paclitaxel sesquiterpene apoptosis Article cancer resistance cell specificity cell viability controlled study drug cytotoxicity drug efficacy drug potentiation drug selectivity female flow cytometry G2 phase cell cycle checkpoint human human cell in vitro study incubation time JC cell line JC pl cell line ovarian cancer cell line ovary cancer OVCAR 3 cell line priority journal SK OV 3 cell line skin fibroblast drug potentiation Ovarian Neoplasms pathology tumor cell line Antineoplastic Agents Antineoplastic Combined Chemotherapy Protocols Cell Line, Tumor Cisplatin Drug Synergism Female Humans Lactones Ovarian Neoplasms Paclitaxel Sesquiterpenes Van Haaften, C Boot, A Corver, W.E Van Eendenburg, J.D Trimbos, B.J Van Wezel, T Synergistic effects of the sesquiterpene lactone, EPD, with cisplatin and paclitaxel in ovarian cancer cells
description	10.1186/s13046-015-0157-2
author2	DUKE-NUS MEDICAL SCHOOL
author_facet	DUKE-NUS MEDICAL SCHOOL Van Haaften, C Boot, A Corver, W.E Van Eendenburg, J.D Trimbos, B.J Van Wezel, T
format	Article
author	Van Haaften, C Boot, A Corver, W.E Van Eendenburg, J.D Trimbos, B.J Van Wezel, T
author_sort	Van Haaften, C
title	Synergistic effects of the sesquiterpene lactone, EPD, with cisplatin and paclitaxel in ovarian cancer cells
title_short	Synergistic effects of the sesquiterpene lactone, EPD, with cisplatin and paclitaxel in ovarian cancer cells
title_full	Synergistic effects of the sesquiterpene lactone, EPD, with cisplatin and paclitaxel in ovarian cancer cells
title_fullStr	Synergistic effects of the sesquiterpene lactone, EPD, with cisplatin and paclitaxel in ovarian cancer cells
title_full_unstemmed	Synergistic effects of the sesquiterpene lactone, EPD, with cisplatin and paclitaxel in ovarian cancer cells
title_sort	synergistic effects of the sesquiterpene lactone, epd, with cisplatin and paclitaxel in ovarian cancer cells
publishDate	2020
url	https://scholarbank.nus.edu.sg/handle/10635/174127
_version_	1778169699279831040

Synergistic effects of the sesquiterpene lactone, EPD, with cisplatin and paclitaxel in ovarian cancer cells

Similar Items